Thyroid hormone receptor β-specific agonist GC-1 increases energy expenditure and prevents fat-mass accumulation in rats

Cássio M. Villicev, Fatima R S Freitas, Marcelo S. Aoki, Cássio Taffarel, Thomas S. Scanlan, Anselmo S. Moriscot, Miriam O. Ribeiro, Antonio C. Bianco, Cecília H A Gouveia

Research output: Contribution to journalArticle

80 Citations (Scopus)

Abstract

It is well known that thyroid hormone affects body composition; however, the effect of the thyroid hormone receptor β (TRβ)-selective thyromimetic GC-1 on this biological feature had not been demonstrated. In the current study, we compared the effects of a 6-week treatment with triiodothyronine (T3; daily injections of 3 or 6 μg/100 g body weight) or GC-1 (equimolar doses) on different metabolic parameters in adult female rats. Whereas all animals gained weight (17-25 g) in a way not basically affected by T3 or GC-1 treatment, only T3 treatment selectively increased food intake (50-70%). Oxygen consumption was significantly and equally increased (50-70%) by T3 and GC-1. Analysis of body composition by dual-energy X-ray absorptiometry (DEXA) revealed that, whereas control animals gained about 80% of fat mass, T3- or GC-1-treated animals lost 70-90 and ∼20% respectively. Direct analysis of the carcass showed that T3 treatment promoted a 14-74% decrease in fat content but GC-1 treatment promoted only a 15-23% reduction. The gain in lean mass by DEXA and the carcass protein content were not affected by T3 or GC-1 treatment. However, the mass of individual skeletal muscles was negatively affected by T3 but only barely by GC-1. These findings highlight the potential use of GC-1 for the treatment of obesity and the metabolic syndrome.

Original languageEnglish
Pages (from-to)21-29
Number of pages9
JournalJournal of Endocrinology
Volume193
Issue number1
DOIs
StatePublished - Apr 1 2007

Fingerprint

Thyroid Hormone Receptors
Energy Metabolism
Fats
Hormones
Photon Absorptiometry
Body Composition
Therapeutics
GC 1 compound
Triiodothyronine
Thyroid Hormones
Oxygen Consumption
Skeletal Muscle
Obesity
Eating
Body Weight
Weights and Measures
Injections

ASJC Scopus subject areas

  • Endocrinology

Cite this

Villicev, C. M., Freitas, F. R. S., Aoki, M. S., Taffarel, C., Scanlan, T. S., Moriscot, A. S., ... Gouveia, C. H. A. (2007). Thyroid hormone receptor β-specific agonist GC-1 increases energy expenditure and prevents fat-mass accumulation in rats. Journal of Endocrinology, 193(1), 21-29. https://doi.org/10.1677/joe.1.07066

Thyroid hormone receptor β-specific agonist GC-1 increases energy expenditure and prevents fat-mass accumulation in rats. / Villicev, Cássio M.; Freitas, Fatima R S; Aoki, Marcelo S.; Taffarel, Cássio; Scanlan, Thomas S.; Moriscot, Anselmo S.; Ribeiro, Miriam O.; Bianco, Antonio C.; Gouveia, Cecília H A.

In: Journal of Endocrinology, Vol. 193, No. 1, 01.04.2007, p. 21-29.

Research output: Contribution to journalArticle

Villicev, CM, Freitas, FRS, Aoki, MS, Taffarel, C, Scanlan, TS, Moriscot, AS, Ribeiro, MO, Bianco, AC & Gouveia, CHA 2007, 'Thyroid hormone receptor β-specific agonist GC-1 increases energy expenditure and prevents fat-mass accumulation in rats', Journal of Endocrinology, vol. 193, no. 1, pp. 21-29. https://doi.org/10.1677/joe.1.07066
Villicev, Cássio M. ; Freitas, Fatima R S ; Aoki, Marcelo S. ; Taffarel, Cássio ; Scanlan, Thomas S. ; Moriscot, Anselmo S. ; Ribeiro, Miriam O. ; Bianco, Antonio C. ; Gouveia, Cecília H A. / Thyroid hormone receptor β-specific agonist GC-1 increases energy expenditure and prevents fat-mass accumulation in rats. In: Journal of Endocrinology. 2007 ; Vol. 193, No. 1. pp. 21-29.
@article{fbd78b23b7af46809a6eeb687843c31d,
title = "Thyroid hormone receptor β-specific agonist GC-1 increases energy expenditure and prevents fat-mass accumulation in rats",
abstract = "It is well known that thyroid hormone affects body composition; however, the effect of the thyroid hormone receptor β (TRβ)-selective thyromimetic GC-1 on this biological feature had not been demonstrated. In the current study, we compared the effects of a 6-week treatment with triiodothyronine (T3; daily injections of 3 or 6 μg/100 g body weight) or GC-1 (equimolar doses) on different metabolic parameters in adult female rats. Whereas all animals gained weight (17-25 g) in a way not basically affected by T3 or GC-1 treatment, only T3 treatment selectively increased food intake (50-70{\%}). Oxygen consumption was significantly and equally increased (50-70{\%}) by T3 and GC-1. Analysis of body composition by dual-energy X-ray absorptiometry (DEXA) revealed that, whereas control animals gained about 80{\%} of fat mass, T3- or GC-1-treated animals lost 70-90 and ∼20{\%} respectively. Direct analysis of the carcass showed that T3 treatment promoted a 14-74{\%} decrease in fat content but GC-1 treatment promoted only a 15-23{\%} reduction. The gain in lean mass by DEXA and the carcass protein content were not affected by T3 or GC-1 treatment. However, the mass of individual skeletal muscles was negatively affected by T3 but only barely by GC-1. These findings highlight the potential use of GC-1 for the treatment of obesity and the metabolic syndrome.",
author = "Villicev, {C{\'a}ssio M.} and Freitas, {Fatima R S} and Aoki, {Marcelo S.} and C{\'a}ssio Taffarel and Scanlan, {Thomas S.} and Moriscot, {Anselmo S.} and Ribeiro, {Miriam O.} and Bianco, {Antonio C.} and Gouveia, {Cec{\'i}lia H A}",
year = "2007",
month = "4",
day = "1",
doi = "10.1677/joe.1.07066",
language = "English",
volume = "193",
pages = "21--29",
journal = "Journal of Endocrinology",
issn = "0022-0795",
publisher = "Society for Endocrinology",
number = "1",

}

TY - JOUR

T1 - Thyroid hormone receptor β-specific agonist GC-1 increases energy expenditure and prevents fat-mass accumulation in rats

AU - Villicev, Cássio M.

AU - Freitas, Fatima R S

AU - Aoki, Marcelo S.

AU - Taffarel, Cássio

AU - Scanlan, Thomas S.

AU - Moriscot, Anselmo S.

AU - Ribeiro, Miriam O.

AU - Bianco, Antonio C.

AU - Gouveia, Cecília H A

PY - 2007/4/1

Y1 - 2007/4/1

N2 - It is well known that thyroid hormone affects body composition; however, the effect of the thyroid hormone receptor β (TRβ)-selective thyromimetic GC-1 on this biological feature had not been demonstrated. In the current study, we compared the effects of a 6-week treatment with triiodothyronine (T3; daily injections of 3 or 6 μg/100 g body weight) or GC-1 (equimolar doses) on different metabolic parameters in adult female rats. Whereas all animals gained weight (17-25 g) in a way not basically affected by T3 or GC-1 treatment, only T3 treatment selectively increased food intake (50-70%). Oxygen consumption was significantly and equally increased (50-70%) by T3 and GC-1. Analysis of body composition by dual-energy X-ray absorptiometry (DEXA) revealed that, whereas control animals gained about 80% of fat mass, T3- or GC-1-treated animals lost 70-90 and ∼20% respectively. Direct analysis of the carcass showed that T3 treatment promoted a 14-74% decrease in fat content but GC-1 treatment promoted only a 15-23% reduction. The gain in lean mass by DEXA and the carcass protein content were not affected by T3 or GC-1 treatment. However, the mass of individual skeletal muscles was negatively affected by T3 but only barely by GC-1. These findings highlight the potential use of GC-1 for the treatment of obesity and the metabolic syndrome.

AB - It is well known that thyroid hormone affects body composition; however, the effect of the thyroid hormone receptor β (TRβ)-selective thyromimetic GC-1 on this biological feature had not been demonstrated. In the current study, we compared the effects of a 6-week treatment with triiodothyronine (T3; daily injections of 3 or 6 μg/100 g body weight) or GC-1 (equimolar doses) on different metabolic parameters in adult female rats. Whereas all animals gained weight (17-25 g) in a way not basically affected by T3 or GC-1 treatment, only T3 treatment selectively increased food intake (50-70%). Oxygen consumption was significantly and equally increased (50-70%) by T3 and GC-1. Analysis of body composition by dual-energy X-ray absorptiometry (DEXA) revealed that, whereas control animals gained about 80% of fat mass, T3- or GC-1-treated animals lost 70-90 and ∼20% respectively. Direct analysis of the carcass showed that T3 treatment promoted a 14-74% decrease in fat content but GC-1 treatment promoted only a 15-23% reduction. The gain in lean mass by DEXA and the carcass protein content were not affected by T3 or GC-1 treatment. However, the mass of individual skeletal muscles was negatively affected by T3 but only barely by GC-1. These findings highlight the potential use of GC-1 for the treatment of obesity and the metabolic syndrome.

UR - http://www.scopus.com/inward/record.url?scp=34247344167&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34247344167&partnerID=8YFLogxK

U2 - 10.1677/joe.1.07066

DO - 10.1677/joe.1.07066

M3 - Article

VL - 193

SP - 21

EP - 29

JO - Journal of Endocrinology

JF - Journal of Endocrinology

SN - 0022-0795

IS - 1

ER -